Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - sildenafil as citrate - film coated tablets - sildenafil as citrate 20 mg - sildenafil - sildenafil - for adults > 18 years: treatment of primary pulmonary hypertension (pph) pulmonary hypertension (ph) associated with connective tissue disease (ctd) or ph following surgical repair at least 5 years previously of atrial septal defect (asd) ventricular septal defect (vsd) patent ductus arteriosus (pda) or aorto-pulmonary window.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - amlodipine as besylate - tablets - amlodipine as besylate 10 mg - amlodipine - mild to moderate hypertension. vasospastic angina ( prinzmetal's or variant angina). chronic stable angina.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - amlodipine as besylate - tablets - amlodipine as besylate 5 mg - amlodipine - mild to moderate hypertension. vasospastic angina ( prinzmetal's or variant angina). chronic stable angina.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - sulfasalazine - tablets enteric coated - sulfasalazine 500 mg - sulfasalazine - sulfasalazine - for active rheumatoid arthritis which is not controlled by antiinflammatory drugs.ulcerative colitis, crohn's disease, pyoderma gangrenosum.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - sulfasalazine - tablets - sulfasalazine 500 mg - sulfasalazine - sulfasalazine - treatment of ulcerative colitis and crohn's disease.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - aluminium chlorohydroxide complex solution; methylprednisolone acetate; neomycin sulfate; sulfur - lotion - methylprednisolone acetate 2.5 mg/ml; neomycin sulfate 2.5 mg/ml; sulfur 50 mg/ml; aluminium chlorohydroxide complex solution 200 mg/ml - methylprednisolone - methylprednisolone - acne.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - clindamycin phosphate - cream - clindamycin phosphate 2 %w/w - clindamycin - clindamycin - treatment of bacterial vaginosis only if bacteria susceptible to clindamycin were found.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - nafarelin acetate - nasal solution - nafarelin acetate 2 mg/ml - nafarelin - nafarelin - - controlled ovarian stimulation programmes prior to in-vitro fertilisation.- hormonal management of endometriosis, including pain relief and reduction of endometrial lesions. - uterine fibroids.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - linezolid - tablets - linezolid 600 mg - linezolid - linezolid - therapy is indicated only when an organism resistant to all other antibiotics is suspected. zyvoxid is indicated in adult and pediatric patients for the treatment of infections when known or suspected to be caused by susceptible organisms including those associated with concurrent bacteraemia such as: 1) pneumonia - community acquired and nosocomial pneumonia including multi drug resistant streptococcus pneumonia (mdrsp). 2) skin and soft tissue infections including diabetic foot infections. 3) enterococcal infections. combination therapy may be indicated if a concomitant gram negative pathogen is documented or suspected.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - fluconazole - capsules - fluconazole 200 mg - fluconazole - fluconazole - fluconazole is indicated in the following fungal infections.fluconazole is indicated in adults for the treatment of:• cryptococcal meningitis.• coccidioidomycosis.• invasive candidiasis.• mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis.• chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient.• vaginal candidiasis, acute or recurrent; when local therapy is not appropriate.• candidal balanitis when local therapy is not appropriate.• dermatomycosis including tinea pedis, tinea corporis, tinea cruris, tinea versicolor and dermal candida infections when systemic therapy is indicated.• tinea unguinium (onychomycosis) when other agents are not considered appropriate.fluconazole is indicated in adults for the prophylaxis of:• relapse of cryptococcal meningitis in patients with high risk of recurrence.• relapse of oropharyngeal or oesophageal candidiasis in patients infected with hiv who are at high risk of experiencing relapse.• to reduce the incidence of recurrent vaginal candidiasis (4 or more episodes a year).• prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving hematopoietic stem cell transplantation).fluconazole is indicated in term newborn infants, infants, toddlers, children, and adolescents aged from 0 to 17 years old:fluconazole is used for the treatment of mucosal candidiasis (oropharyngeal, oesophageal), invasive candidiasis, cryptococcal meningitis and the prophylaxis of candidal infections in immunocompromised patients. fluconazole can be used as maintenance therapy to prevent relapse of cryptococcal meningitis in children with high risk of reoccurrence. therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, anti infective therapy should be adjusted accordingly.consideration should be given to official guidance on the appropriate use of antifungals.